Nuove tecniche di dosaggio: la Cloned Enzyme Donor Immuno Assay (CEDIA)

2004

Molecular analysis of the APP gene overexpression and his relationship with early onset of Alzheimer Dementia in young adults with Down Syndrome

2004

Mutation analysis of the ΔR 608 mutation causing Niemann-Pick disease type B from blood spot cards in sicilian people

2004

Low serum fetuin-A in renal failure patients on Hemodialisis

2005

Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections.

2004

Abstract Background: The flogosis markers currently in use show both low sensitivity and specificity, particularly in neoplastic and degenerative diseases. Procalcitonin (PCT) is a pro-peptide of calcitonin produced mainly but not only in the C-cells of the thyroid glands and, as several studies show, PCT levels in plasma increase during infections. Bacterial infections are also the main cause of death in oncological patients. Furthermore, in patients with leukaemia in chemotherapy recovery, infections often induce relapses. The aim of the present study is to detect PCT levels in plasma in oncohaematologic patients with and without infections. Methods: The study was carried out on 54 patien…

Biochimica e Fisiopatologia delle Specie Reattive dell’Ossigeno

2005

Procalcitonin levels in plasma in oncohaematologic patients with an without bacterial infections

2004

BACKGROUND: The flogosis markers currently in use show both low sensitivity and specificity, particularly in neoplastic and degenerative diseases. Procalcitonin (PCT) is a pro-peptide of calcitonin produced mainly but not only in the C-cells of the thyroid glands and, as several studies show, PCT levels in plasma increase during infections. Bacterial infections are also the main cause of death in oncological patients. Furthermore, in patients with leukaemia in chemotherapy recovery, infections often induce relapses. The aim of the present study is to detect PCT levels in plasma in oncohaematologic patients with and without infections. METHODS: The study was carried out on 54 patients by a q…

Metabolic sindrome and increased risk for cardiovascular disease

2005

Assunzione di alcool e markers di abuso

2004

Serum Fetuin A concentration in patients on haemodialysis

2005

LINEE GUIDA PER L'ANALISI DELLE SOSTANZE D'ABUSO IN CAMPIONI BIOLOGICI

2004

Low Fetuin-A plasma levels are associated with the presence of carotid plaques in patients on dialysis.

2006

Biochimica clinica dello stress ossidativo

2005

Genetic analysis about the wellknown relationship between Alzheimer Demaentia outbreak and APP gene overexpression in Down young patients

2004

Evaluations and new relationships between renal failure and homocysteine plasma levels in patients with chronic renal failure

2004

The Homocysteine System

2006

Plasma homocysteine levels in patients with chronic renal failure.

2004

Plasma homocysteine levels in patients with metabolic syndrome

2005

Evaluation of plasma homocysteine levels and metabolic sindrome in patients with cardiovascular disease

2005

Plasma omocysteine levels in patients with chronic renal failure

2004

Evaluation of patients with thrombotic stroke by methionine loading oral curve

2004

Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica

2004

Genetic testing on Dry Blood Spot Card samples of Sicilian people in aim to check out the ΔR 608 mutation causing Niemann-Pick Disease Type B.

2004

Low serum Fetuin A levels in renal failure patients on haemodialysis

2005